Patent Number: 6,310,183

Title: Coagulation factor VIIa composition

Abstract: The invention relates to a pharmaceutical composition comprising Factor VIIa for subcutan, intramuscular or interdermal administration. Factor VIIa administered subcutanously, intramuscularly or intradermally shows a sufficient transport into the bloodstream in biologically active form and in adequate concentrations, and favorable pharmacokinetic properties.

Inventors: Johannessen; Marie (Birker.o slashed.d, DK), Nordfang; Ole Juul (Hiller.o slashed.d, DK), Jansen; Jens Aas (Charlottenlund, DK)

Assignee: Novo Nordisk A/S

International Classification: A61K 38/48 (20060101); A61K 38/43 (20060101); A61K 035/14 (); A61K 038/48 ()

Expiration Date: 10/30/2018